NeuroBo Pharmaceuticals Inc (NRBO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 21, 16:00
4.40
0.00 (0.00%)
After-Hours: 19:41
NeuroBo Pharmaceuticals Free Cash Flow: -14.74M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.74M |
| December 31, 2023 | -10.85M |
| September 30, 2023 | -9.254M |
| June 30, 2023 | -8.762M |
| March 31, 2023 | -9.434M |
| December 31, 2022 | -11.71M |
| September 30, 2022 | -12.80M |
| June 30, 2022 | -12.95M |
| March 31, 2022 | -13.82M |
| December 31, 2021 | -15.14M |
| September 30, 2021 | -14.59M |
| June 30, 2021 | -14.04M |
| March 31, 2021 | -12.77M |
| December 31, 2020 | -10.77M |
| September 30, 2020 | -9.792M |
| June 30, 2020 | -11.28M |
| March 31, 2020 | -10.17M |
| Date | Value |
|---|---|
| December 31, 2019 | -7.039M |
| September 30, 2019 | -2.414M |
| June 30, 2019 | -3.353M |
| March 31, 2019 | -8.439M |
| December 31, 2018 | -14.45M |
| September 30, 2018 | -24.56M |
| June 30, 2018 | -27.57M |
| March 31, 2018 | -27.91M |
| December 31, 2017 | -26.90M |
| September 30, 2017 | -23.76M |
| June 30, 2017 | -20.10M |
| March 31, 2017 | -15.21M |
| December 31, 2016 | -11.04M |
| September 30, 2016 | -9.676M |
| June 30, 2016 | -7.604M |
| March 31, 2016 | -6.869M |
| December 31, 2015 | -5.433M |
Free Cash Flow Range, Past 5 Years
-15.14M
Minimum
Dec 2021
-2.414M
Maximum
Sep 2019
-10.78M
Average
-11.06M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.896B |
| SIGA Technologies Inc | 64.23M |
| Vanda Pharmaceuticals Inc | -11.77M |
| Tenon Medical Inc | -11.34M |
| NovaBay Pharmaceuticals Inc | -4.524M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.442M |
| Cash from Investing (Quarterly) | -0.005M |
| Free Cash Flow Per Share (Quarterly) | -1.267 |
| Free Cash Flow Yield | -65.98% |